NCT05468879 - Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 21, 2020

Primary Completion Date

October 23, 2020

Study Completion Date

January 6, 2021

Conditions

Drug Use

Interventions

DRUG

Glimepiride

Glimepiride is a sulfonylurea, indicated as an adjunct to proper dietary management, exercise and weight reduction to lower the blood glucose in patients with type 2 diabetes whose hyperglycemia cannot be controlled by diet and exercise alone.

DRUG

Amaryl®

Trial Locations (1)

10520

PT Pharma Metric Labs, Jakarta